Home > Press > Cedrus Investments Ltd. Launches Two Global Nanotechnology Indices
Abstract:
Cedrus Investments Ltd. ("Cedrus") a boutique investment firm, today announced the formal launch of two global nanotechnology indices - Cedrus Nanotechnology Index - Diversified ("CNID") and Cedrus Nanotechnology Index - Pure ("CNIP"). These indices are designed to serve as benchmarks for professional investors to capitalize on the fastest growing technology companies spanning the five markets most impacted by nanotechnology (i.e., manufacturing, electronics, energy, life sciences and environment).
Cedrus maintains two indices in order to meet the needs of diverse investors. Cedrus' diversified index (CNID) includes 220 equally-weighted companies spanning all five nano-markets and is inclusive of both diversified companies that have nanotechnology as only one of many growth drivers, and pure-play companies that have nanotechnology as their primary driver of growth. Cedrus' pure index (CNIP) is a concentrated index, comprised of 67 equally-weighted pure-play companies spanning all five nano-markets and best-suited for small cap investors.
Kimberly Nearing, Executive Vice President said, "Companies developing nanotechnology have been among the best performing stocks over the past decade. While the past is no guarantee of the future, we believe their outperformance will continue, led by strong growth in innovation and demand for their products and services."
Cedrus' nanotechnology indices differ from others in that they are broader, including more than the typical 10-30 company names, and they are equally-weighted, rather than being market cap-weighted. Broader indices minimize company and market segment specific risk and volatility, and more readily capture emerging opportunities. They have a low correlation to the market and other more general technology indices. Equally-weighted indices, by definition, give equal importance to all members, making them superior comparative benchmarks to use within a specific industry, such as nanotechnology.
Leading companies within each index will be covered by high-quality, objective and actionable fundamental research. Both indices will be rebalanced quarterly to reflect structural changes in this dynamic industry and ETF versions of each will be launched shortly.
Paul Jackson, Chief Investment Officer commented, "These two indices take the pulse of the future in this dynamic and increasingly important industry, which already encompasses the great technology engine of the 20th and 21st centuries, semiconductors."
####
About Cedrus Investments Ltd. (“Cedrus”)
Cedrus Investments Ltd. is a boutique investment firm that offers Wealth Management, Asset Management, Investment Banking Advisory Services, Institutional Sales & Trading and Prime Brokerage to a clientele of leading institutional investors, corporations, family offices and high net worth individuals from around the world.
For more information, please click here
Contacts:
Cedrus Investments Ltd.
Liz Lynee
345-769-7100
Copyright © Business Wire 2009
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||